Dermatology Drug Developer Hits Ch. 11 With Sale Plan
By Yun Park · November 20, 2023, 5:12 PM EST
Dermatology treatment developer Timber Pharmaceuticals Inc. filed for Chapter 11 in Delaware bankruptcy court, saying it wants to sell its assets to a failed pre-bankruptcy merger partner....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login